Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-22T23:57:55.977Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa

Published online by Cambridge University Press:  02 January 2015

Erico A.G. Arruda ,
Ivan S. Marinho ,
Marcos Boulos ,
Sumiko I. Sinto ,
Helio H. Caiaffa F ,
Caio M. Mendes ,
Carmen P. Oplustil ,
Helio Sader ,
Carlos E. Levy  and
Anna S. Levin
Erico A.G. Arruda
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Ivan S. Marinho
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Marcos Boulos
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Sumiko I. Sinto
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Helio H. Caiaffa F
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Caio M. Mendes
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Carmen P. Oplustil
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Helio Sader
Affiliation:
Federal University of São Paulo, São Paulo, Brazil
Carlos E. Levy
Affiliation:
University of São Paulo, Ribeirāo Preto, Brazil
Anna S. Levin*
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
*
Rua Harmonia, 564/52, São Paulo - SP 05435-000, Brazil
Get access Rights & Permissions [Opens in a new window]

Abstract

A case-control study was done to evaluate factors associated with nosocomial infections by multiresistant Pseudomonas aeruginosa (MRPA). Results showed that MRPA was associated with the use of immunosuppressive and antimicrobial drugs. Five typing methods indicated that the MRPA infections were due to multiple strains rather than a single strain.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 9 , September 1999 , pp. 620 - 623
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gaynes, PR, Culver, DH. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:10–14.CrossRefGoogle ScholarPubMed
2. Garner, JS, Jarvis, WR, Emori, TG. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128–140.CrossRefGoogle ScholarPubMed
3. Knaus, WA, Draper, EA, Wagner, DP, Zimmerman, JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–829.CrossRefGoogle ScholarPubMed
4. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standards. 1990;M2–T4. Abstract.Google Scholar
5. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. Approved standards. 1990;M7–A2. Abstract.Google Scholar
6. Tenover, FC. Plasmid fingerprint of gram-negative organisms. In Isenberg, HD, ed. Clinical Microbiology Procedures Handbook. Washington, DC: ASM; 1992.Google Scholar
7. Kunin, CM. Resistance to antimicrobial drugs—a worldwide calamity. Ann Intern Med 1993;118:557–561.CrossRefGoogle ScholarPubMed
8. McGowan, JE Jr. Antibiotic-resistant bacteria and healthcare system: four steps for effective response. Infect Control Hosp Epidemiol 1995;16:67–70.CrossRefGoogle ScholarPubMed
9. Krcmery, V Jr, Trup, J, Kunova, A, Spanik, S, Drgona, L, Oravcova, E, et al. Imipenem-resistant Pseudomonas aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Int J Clin Pharmacol Res 1996;16:43–49.Google ScholarPubMed
10. Döring, G, Hörz, M, Ortelt, J, Grupp, H, Wolz, C. Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit. Epidemiol Infect 1993;110:427–436.CrossRefGoogle Scholar